We are live on ! Find out more
VTAK icon

Catheter Precision
VTAK

10 hedge funds and large institutions have $383K invested in Catheter Precision in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

25% more funds holding

Funds holding: 8 → 10 (+2)

0.02% less ownership

Funds ownership: 0.06% → 0.04% (-0.02%)

58% less capital invested

Capital invested by funds: $904K → $383K (-$522K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Baird Financial Group
Baird Financial Group
Wisconsin
+$122K
2
Citadel Advisors
Citadel Advisors
Florida
+$21.2K
3
VF
Virtu Financial
New York
+$15.4K
4
UBS Group
UBS Group
Switzerland
+$3.69K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$351K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$23.4K
3
Renaissance Technologies
Renaissance Technologies
New York
-$5.07K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$231
5
Osaic Holdings
Osaic Holdings
Arizona
-$153
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$192K -$351K -1,521 -58%
Baird Financial Group
2
Baird Financial Group
Wisconsin
$92.5K +$122K +529 New
Renaissance Technologies
3
Renaissance Technologies
New York
$33K -$5.07K -22 -10%
BlackRock
4
BlackRock
New York
$17K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$16.1K +$21.2K +92 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$12.1K -$231 -1 -1%
VF
7
Virtu Financial
New York
$12K +$15.4K +67 New
TRCT
8
Tower Research Capital (TRC)
New York
$4.73K – – –
UBS Group
9
UBS Group
Switzerland
$2.76K +$3.69K +16 New
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Quebec, Canada
$184 – – –
Bank of America
11
Bank of America
North Carolina
$85 – – –
Wells Fargo
12
Wells Fargo
California
$33 – – –
APC
13
Aspire Private Capital
North Carolina
$18 – – –
HI
14
Harbour Investments
Wisconsin
$18 – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
– -$23.4K -80 Closed
Osaic Holdings
16
Osaic Holdings
Arizona
– -$153 -1 Closed

VTAK Hedge Fund Activity: Q2 2023 in Review

10 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2023, worth a combined $383K — down 58% from $904K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new VTAK positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Baird Financial Group, opening a new position worth an estimated $122K. The largest seller was Armistice Capital, cutting an estimated $351K.

  • 10 institutional investors held Catheter Precision (VTAK) as of Q2 2023, up from 8 in Q1 2023.
  • Funds reported $383K of Catheter Precision stock for Q2 2023, down 58% quarter-over-quarter.
  • 4 funds opened new Catheter Precision positions in Q2 2023 and 2 closed out, a net change of +2 holders.
  • The largest Catheter Precision buyer in Q2 2023 was Baird Financial Group, an estimated $122K added.
  • The largest Catheter Precision seller in Q2 2023 was Armistice Capital, an estimated $351K sold.

Based on aggregated 13F filings for Q2 2023.